Amy E. Zartman

Nonpeptide α_vβ₃ Antagonists. 8. In Vitro and in Vivo Evaluation of a Potent α_vβ₃ Antagonist for the Prevention and Treatment of Osteoporosis

John H. Hutchinson, Wasyl Halczenko, Karen M. Brashear et al. · Journal of Medicinal Chemistry · 2003 · 96 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Nonpeptide α_vβ₃ Antagonists. 1. Transformation of a Potent, Integrin-Selective α_IIbβ₃ Antagonist into a Potent α_vβ₃ Antagonist

Mark E. Duggan, Le T. Duong, John Fisher et al. · Journal of Medicinal Chemistry · 2000 · 88 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Synthesis of 2-(alkylamino)benzimidazoles

James J. Perkins, Amy E. Zartman · Tetrahedron Letters · 1999 · 57 citations

Synthesis and evaluation of a new series of Neuropeptide S receptor antagonists

Jeffrey Y. Melamed, Amy E. Zartman, Nathan R. Kett et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 26 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Decahydroquinoline amides as highly selective CB2 agonists: Role of selectivity on in vivo efficacy in a rodent model of analgesia

Peter J. Manley, Amy E. Zartman, Daniel V. Paone et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 20 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15